by CyberKnife Miami | Oct 6, 2026 | Brain Tumor Treatment With CyberKnife
CyberKnife Moves Beyond Neurosurgery: There are over 200 thousand brain tumor cases a year, but today only 15% are treated by neurosurgeons. The vast majority are treated non-invasively by radiation oncologists using stereotactic body radiation therapy (SBRT) like...
by CyberKnife Miami | Oct 3, 2026 | Improved Imaging Equals a Better Outcome
Madison, Wis. — Accuray, the manufactuer of CyberKnife Radition Therapy has entered into agreements with Samsung HME America, doing business as NeuroLogica Corp., to pursue advanced volumetric imaging capabilities for the CyberKnife System. The companies announced...
by CyberKnife Miami | Sep 30, 2026 | CyberKnife vs. Surgery for Prostate Cancer
For John, staying active has always been an important part of life. He enjoys being outdoors, working around his rural property. So, when he was diagnosed with prostate cancer, finding a treatment option that aligned with his lifestyle and his evidence-based approach...
by CyberKnife Miami | Sep 27, 2026 | Active Surveillance vs. Treatment for Prostate Cancer
Active surveillance for cancer patients does not mean ignoring the disease, it means closely watching it rather than immediately treating it. While most of the time active surveillance is associated with prostate cancer, it can be associated with other cancers as...
by CyberKnife Miami | Sep 27, 2026 | PSMA PET Scan
CT scans, MRIs and bone scans have long been used to diagnose and stage prostate cancer. But doctors have a new imaging tool that could work even better. It’s called a PSMA PET scan, and it uses molecular imaging targeting the prostate-specific membrane antigen or...
